Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2026)
Legend Biotech (LEGN) posted quarterly Asset Utilization Ratio of 0.68 for Q1 2026, up 54.29% year-on-year from 0.44 in Q1 2025, and up 14.57% on a QoQ basis from 0.6 in Q4 2025.
Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has reported Asset Utilization Ratio for 7 consecutive years, with 0.68 the latest figure, recorded in Q1 2026.
- Quarterly Asset Utilization Ratio rose 54.29% year-over-year to 0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.68 (up 54.29% YoY) and the FY2025 annual result came in at 0.6, up 69.56% from the prior year.
- Asset Utilization Ratio improved to 0.68 in Q1 2026 per LEGN's latest filing, from 0.6 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for LEGN reached as high as 45.22 in Q3 2024 and fell as low as 0.08 in Q1 2023.
- A 5-year average of 12.9 and a median of 0.51 in 2025 frame the typical range for Asset Utilization Ratio.
- The largest YoY upside for Asset Utilization Ratio was 54004.99% in 2024 against a maximum downside of 99.15% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.12 in 2022, then jumped by 36951.55% to 43.21 in 2023, then plunged by 99.15% to 0.37 in 2024, then jumped by 62.07% to 0.6 in 2025, then grew by 14.57% to 0.68 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.68, 0.6, and 0.53 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Legend Biotech | 8.69 Bn | 7.79 Bn | 129.70 Mn | 0.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.53 |
| Jun 30, 2025 | 0.48 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | 45.22 |
| Jun 30, 2024 | 44.69 |
| Mar 31, 2024 | 44.00 |
| Dec 31, 2023 | 43.21 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.08 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 0.00 |